Facial Pain
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
PriZm TherapeuticsAZ - Chandler
1 programHalo Craniofacial Nerve Stimulator SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AmgenErenumab Prefilled Syringe
PriZm TherapeuticsHalo Craniofacial Nerve Stimulator System
Clinical Trials (2)
Total enrollment: 89 patients across 2 trials
Erenumab for Idiosyncratic Facial Pain
Start: Feb 2021Est. completion: Jul 202329 patients
Phase 4Completed
Clinical Trial of Wireless CranioFacial Nerve Stimulation (CFNS) for the Treatment of CranioFacial Neuropathic Pain
Start: Feb 2017Est. completion: Oct 202260 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space